American Marconi Wireless News

NYSE - LSE

RBGPF	-19.57%	69	$
GSK	-0.26%	58.21	$
CMSC	0.18%	22.43	$
RELX	-0.12%	33.3	$
AZN	-0.47%	204.03	$
NGG	-0.03%	90.29	$
BTI	-0.07%	58.81	$
RIO	1.15%	98.26	$
BP	1.16%	46.44	$
BCE	-2.31%	23.35	$
RYCEF	-1.59%	16.96	$
CMSD	0.18%	22.63	$
VOD	-1.02%	15.69	$
BCC	-0.51%	80.17	$
JRI	0.31%	13.02	$

Featured

Artemis crew urges unity on 'lifeboat' Earth

Artemis II astronauts expressed awe on Saturday over their record-setting lunar flyby mission, urging unity on Earth after witnessing the planet's isolation like a "lifeboat" in space.

After Artemis II, NASA looks to SpaceX, Blue Origin for Moon landings

With Artemis II successfully completing its historic lunar mission on Friday, NASA is banking on billionaires Jeff Bezos and Elon Musk for the next step: landing astronauts on the Moon.

Last news

Ayrmid Pharma Ltd Announces Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia (SAA) Presented at TANDEM

Omisirge transplantation shows accelerated immune recovery in SAANew data presented at the 2026 TANDEM Meetings demonstrate that patients with SAA who received Omisirge experienced faster and more robust immune recovery compared with patients receiving alternative transplant graft sourcesOmisirge approved by FDA as First Cell Therapy to Treat Severe Aplastic AnemiaKey Highlights of Data Presented at TANDEM:Rapid neutrophil recovery: Median time to neutrophil engraftment was 10 days following Omisirge transplantation. Faster recovery was associated with higher transplanted CD34⁺ cell dosesEnhanced CD4⁺T-cell reconstitution: At six months post-transplant, CD4⁺ T-cell counts were significantly higher in Omisirge recipients compared with other transplant sources including matched and haploidentical donors. Higher CD4⁺ T-cell recovery correlated with more rapid neutrophil engraftmentAccelerated NK-cell recovery: Natural killer (NK) cell reconstitution occurred early after transplant, with median NK-cell counts at days 30 and 100 exceeding those observed across all comparator graft sourcesOmisirge approved by the FDA on December 5, 2025 for SAA

TrackVia to Showcase Modern Operations Management Technology at WEST 2026

Advanced low-code workflow platform helps streamline mission-critical programs, processes and procedures for greater visibility and control anywhere, anytime.

CyberGuard Advantage Strengthens Executive Leadership Team with Key Appointments to Scale Global Operations

Dylan Anderson (CRO), Neetu Jindal (CHRO), and Jeni Bahr (CFO) join the cybersecurity and compliance leader to drive operational excellence and long-term growth.

Whack-a-mole: US academic fights to purge his AI deepfakes

As deepfake videos of John Mearsheimer multiplied across YouTube, the American academic rushed to have them taken down, embarking on a grueling fight that laid bare the challenges of combating AI-driven impersonation.

enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Company achieves minimum $1.00 closing bid for 10 consecutive business days; Nasdaq confirms matter is closedReports Cash and Investments of approximately $28 million as of the Year Ended December 31, 2025

Datametrex Expands Business In Data Centres

TORONTO, ONTARIO / ACCESS Newswire / February 4, 2026 / Datametrex AI Limited (the "Company" or "Datametrex") (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce the continued expansion of its business into modern data centre operations & infrastructure solutions business. As part of this expansion, the Company is deploying Nutanix-based hyperconverged infrastructure (HCI) solutions, which unify servers, storage, and networking into a single, integrated platform designed to enhance operational stability, scalability, processing speed, and capacity efficiencies. Currently, the company has had good success deploying in South Korea with these solutions. These solutions have had stronger performance than traditional based VMware products. The company looks to rollout these specific solutions in North America.

Nextech3D.ai Expands Krafty Lab Enterprise Engagement Platform with F-35 Flight Simulation Experiences Through The Squadron Partnership

Partnership with The Squadron Introduces High-Fidelity Flight Simulation for Enterprise Leadership Development, Executive Offsites and Premium Engagement Programs

iBLOXX Secures USD 5.4 Million for Global Launch of StrayShot

iBLOXX Studios DMCC has raised USD 5.4 million to finalize development and support the global launch of its mobile-first third-person shooter, StrayShot. Based in Dubai and part of the DMCC Gaming Centre and Dubai Program for Gaming 2033, the studio collaborates with partners like the Dubai Future Foundation and Xsolla. StrayShot features multiple modes (Battle Royale, Team Deathmatch, Extraction), is optimized for low-end devices, and is set in the fictional region of Sierra Verde. Currently in closed testing, the game will include blockchain-enabled asset ownership. The funding will fuel global marketing, live operations, ongoing updates, and future console versions.

Seven Oshyn Experts Honored with 2026 Sitecore Most Valuable Professional Awards

Seven specialists recognized for their technical mastery and strategic leadership within the global Sitecore ecosystem.

GameSquare Appoints Amaree Tanawong as Chief Operating Officer

Tanawong brings nearly two decades of experience scaling strategy, monetization, and operational platforms across YouTube, Meow Wolf, Fullscreen, and Yahoo

iTacit Forecasts Workforce Enablement Trends for 2026

The frontline-first workforce technology company predicts five trends in how organizations will respond to challenges of slow, fragmented, and ineffective training systems.

Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U.S. Phase III FDA Trial

GelrinC, the only restorative product for knee cartilage repair, has CE Mark approval in Europe and is currently at the midpoint of a pivotal FDA Phase III trial in the U.S.Ori Gon brings substantial public company, medtech, and capital markets experience

ProScore Technologies Announces Strategic Partnership with Qcells to Support Compliance and Workforce Management for Utility-Scale Clean Energy Projects

AI-Powered Platform to Serve as System of Record for Compliance Across Qcells' U.S. Project Development and Construction Activities

New Report from The Modern Data Company Finds the Data Activation Gap Is Holding Back Enterprise AI and Decision-Making

The Modern Data Report 2026 reveals that 68% of data practitioners say their data isn't reliable enough for AI, and 87% say better data (trusted, contextual, and easily accessible across teams) would improve decision speed.

Ayrmid Reports Additional New Real-World Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease and Beta-Thalassemia

Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease and beta-thalassemia enabling accelerated access to gene therapies73% (11 of 15) of patients were able to collect sufficient HSC to enable progress to gene therapy manufacturing with 5 patients receiving their gene therapy and appropriately engrafted73% (11 of 15) of patients had previously failed to collect sufficient cells with plerixaforResults support the use of motixafortide as an effective single-agent mobilizer of HSC for people with sickle cell disease and in combination with G-CSF for beta-thalassemiaFindings presented at TANDEM 2026

CAVU Resources, Inc. (OTC:CAVR) Provides Update on Timeline for Proposed Merger with Post Bid Ship, Inc.

TULSA, OKLAHOMA / ACCESS Newswire / February 4, 2026 / CAVU Resources, Inc. ("CAVR" or the "Company"), OTC, today issued an update regarding the timeline for its proposed spin-out and merger with Post Bid Ship, Inc. and PBS Recon, Inc.

ATREYD'S Secures $44.9 Million Security Contract to Protect Strategic Energy Infrastructure with Autonomous, Unmanned Defense Systems

Deal includes delivery of new CIRCEE Unmanned Surface Vessels, reflecting the growing need to defend critical infrastructure against modern, asymmetric threats

Candescent and Greenlight Partner to Build the Next Generation of Financially Empowered Families

Collaboration enables banks and credit unions with a powerful way to offer families lifelong money skills, and grow loyalty for generations

Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant

Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant)

Preservica Redefines Digital Preservation with Powerful Built-In AI Tools

OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow.

Expert Intelligence Raises $4.7M Seed Round to Automate Expert Judgment in Regulated Labs

SANTA CLARA, CA / ACCESS Newswire / February 4, 2026 / Expert Intelligence™, a startup building AI systems that automate expert decision-making in regulated laboratory environments, today announced it has raised a $4.7M seed round led by Sierra Ventures with participation from TSVC and Acorn Pacific Ventures.

Bebuzee ($BBUZ) Sets the Stage for Global Push with Strategic Series of Super App Updates

MIAMI, FL / ACCESS Newswire / February 4, 2026 / Bebuzee Inc. ($BBUZ), the rapidly evolving next-generation super app company, today announced a strategic sequence of major platform updates scheduled over the next three consecutive release windows - this weekend, next weekend, and again in two weeks - designed to prime the platform for an expanded global push.

CuriosityStream Declares Quarterly Cash Dividend

Dividend supported by continued and recurring free cash flow generation and expanding AI-driven data licensing activities

Water Tower Research Fireside Chat with Ainos: AI Nose Powering SmellTech Expansion and Scalable Value Creation

AI Nose advances through a dual-engine architecture, enabling scalable deploymentsIndustrial and semiconductor deployments broaden Ainos' commercial footprintRobotics momentum accelerates data flywheel growth and commercial scale-up in 2026

CORRECTION FROM SOURCE: Expert Intelligence Raises $5.8 Million Seed Round to Bring AI Decision Automation to Regulated Laboratories

Updated funding amount

UBS grilled on Capitol Hill over Nazi-era probe

A Senate panel grilled UBS officials Tuesday over withholding documents sought in a probe of Holocaust-era assets stolen by Nazis and held at Credit Suisse.

NASA Moon mission launch delayed to March after test

NASA said Tuesday it's delaying until March the launch of its first crewed flyby mission to the Moon in more than 50 years, after encountering leaks during final tests.

Paying for a selfie: Rome starts charging for Trevi Fountain

Italy's Trevi Fountain launched a new ticketing system Monday, making the famous Rome landmark the latest tourist site to charge entry in a bid to raise funds and battle overcrowding.

2025 Upgraded Guidance On Backlog And Revenue

COLLEFERRO, IT / ACCESS Newswire / February 3, 2026 / On 29 January 2026 the Board of Directors of Avio S.p.A. ("Avio" or the "Company") reviewed and approved an upgrade of its guidance for order backlog and net revenues for FY 2025.

Lobe Sciences Reports First Quarter 2026 Results and Highlights

VANCOUVER, BC / ACCESS Newswire / February 3, 2026 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE.F) ("Lobe" or the "Company"), a biopharmaceutical company advancing programs in diseases with unmet medical needs, today reported unaudited financial results for the first quarter of fiscal 2026 ended November 30, 2025 (Q1:2026) and provided an update on operational progress for the quarter.

OneDosh Raises $3M Pre-Seed to Build Stablecoin-Powered Infrastructure for Cross-Border Payments

The pre-seed funding will be used to expand into additional payment corridors, deepen liquidity partnerships, and support senior team hires

Nextech3D.ai's Krafty Lab Signs New Multinational "Tier 1" Enterprise Agreement and Expands Global In-Person Enterprise Event Delivery

Enterprise-Grade Global Event Platform Now Supports International In-Person Delivery for Distributed Teams

American Marconi Wireless News - Technology (English)